Innovation and night light in large and small cities. حسب Saul Estrin (8629173)

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. حسب William C. Barley (8915282)

الموضوعات:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). حسب William C. Barley (8915282)

الموضوعات:

Summary map of all contacts with statistically significant SVM classifications. حسب Alexander P. Rockhill (6053618)

"…<p>The top row presents the proportion of significant SVM clusters. It illustrates what proportions of channels are significant at that time-frequency ranging from 0 to 1. …"

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)

Introgression decreases allelic shuffling. حسب Enrique J. Schwarzkopf (6579275)

Why does task performance decrease with burst length? حسب Swathi Anil (17382903)

Flow chart of participants selection. حسب Linjia Duan (13276989)

الموضوعات:

Sobel test for the significance of the mediation effect. حسب Getachew Magnar Kitila (19935139)

Sensitivity to small changes. حسب Ariel Burman (20329776)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. حسب Marc Van Der Hofstadt (1423027)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات: